miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Open Access
- 24 August 2022
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 17 (2) , 463-475
Abstract
Background and aims: Numerous studies have demonstrated that hepatic fibrosis, a progressive condition as an endpoint of multiple chronic hepatic diseases, is largely characterized with the extensive activation of hepatic stellate cells (HSCs). The precise effect of miR-488-5p in HSCs during hepatic fibrosis has not been elucidated. Methods: In our study, qRT‐PCR was applied to assess the level of miR-488-5p in activated HSCs stimulated by TGF-β1. We built murine liver fibrosis models with carbon tetrachloride (CCl4), high-fat diet (HFD) and bile duct ligation (BDL). In vitro, the effects of miR-488-5p in HSCs were examined through cell proliferation assay and apoptosis. Luciferase reporter assay was applied to identify the underlying target of miR-488-5p. In vivo, the effects of miR-488-5p were explored through mouse liver fibrosis models. Results: The reduction of miR-488-5p in the activated HSCs induced by TGF-β1 and three mouse hepatic fibrosis models were identified. The in vitro functional experimentations verified that miR-488-5p restrained expression of fibrosis-related markers and proliferative capacity in HSCs. Mechanically, we identified that miR-488-5p inhibited tet methylcytosine dioxygenase 3 (TET3) expression via straightly binding onto the 3′ UTR of its mRNA, which sequentially restrained the TGF-β/Smad2/3 pathway. TET3 inhibition induced by the overexpression of miR-488-5p reduced extracellular matrix deposition, which contributed to mitigating mouse liver fibrosis. Conclusion: We highlight that miR-488-5p restrains the activation of HSCs and hepatic fibrosis via targeting TET3 which is involved in the TGF-β/Smad2/3 signaling pathway. Collectively, miR-488-5p is identified as a potential therapeutic target for hepatic fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (81572393, 81972888, 81602093)
- Key Laboratory in Science and Technology Development Project of Suzhou (ZKX15020, ZKX17022)
This publication has 41 references indexed in Scilit:
- MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of MethyltransferasesInternational Journal of Molecular Sciences, 2017
- The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell InfiltrationInternational Journal of Molecular Sciences, 2017
- TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue PhysiologyCold Spring Harbor Perspectives in Biology, 2016
- TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS1.2014
- Tet family proteins and 5-hydroxymethylcytosine in development and diseaseDevelopment, 2012
- Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNAScience, 2011
- TET Family Proteins and Their Role in Stem Cell Differentiation and TransformationCell Stem Cell, 2011
- Pathogenesis of Liver FibrosisAnnual Review of Pathology: Mechanisms of Disease, 2011
- Liver fibrosisJournal of Clinical Investigation, 2005
- Is liver fibrosis reversible?Gut, 2000